2.78
Intelligent Bio Solutions Inc stock is traded at $2.78, with a volume of 15,956.
It is up +0.36% in the last 24 hours and down -30.50% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
See More
Previous Close:
$2.77
Open:
$2.75
24h Volume:
15,956
Relative Volume:
0.07
Market Cap:
$5.56M
Revenue:
$3.58M
Net Income/Loss:
$-11.33M
P/E Ratio:
-0.2535
EPS:
-10.9665
Net Cash Flow:
$-9.75M
1W Performance:
+4.91%
1M Performance:
-30.50%
6M Performance:
-74.02%
1Y Performance:
-77.94%
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-790-5756
Address
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INBS
Intelligent Bio Solutions Inc
|
2.78 | 5.54M | 3.58M | -11.33M | -9.75M | -10.97 |
|
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
How cyclical is Intelligent Bio Solutions Incs revenue stream2026 Price Swings & Smart Money Movement Tracker - baoquankhu1.vn
INBS Stock Price, Quote & Chart | INTELLIGENT BIO SOLUTIONS IN (NASDAQ:INBS) - ChartMill
INBS Advances FDA Approval with Successful Initial Study - GuruFocus
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market - Bitget
Intelligent Bio Solutions Completes Clinical Cut-Off Study - TradingView — Track All Markets
INBS Stock Falls After Clinical Study Win: FDA Progress Fails To Lift Shares - Stocktwits
A fingerprint drug test moved closer to a U.S. launch after codeine study - Stock Titan
Published on: 2026-03-31 09:14:37 - baoquankhu1.vn
Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant - Bitget
Intelligent Bio Solutions receives European patent for drug testing tech - Investing.com
Intelligent Bio Solutions receives European patent for drug testing tech By Investing.com - Investing.com India
A fingerprint sweat drug test just won its 8th European patent - stocktitan.net
Intelligent Bio Solutions Inc. Announces 2026 Restricted Stock Award Agreements and Incentive Plan Updates - Minichart
Intelligent Bio Solutions Grants Equity Awards, Updates ATM Capacity - The Globe and Mail
Intelligent Bio Solutions grants equity to CEO Harry Simeonidis and CFO Spiro Sakiris - TradingView
Intelligent Bio Solutions (NASDAQ: INBS) details new equity awards, ATM capacity - Stock Titan
INBS (NASDAQ: INBS) files ATM with Ladenburg to raise up to $3.97M - Stock Titan
If You Invested $1,000 in Intelligent Bio Solutions Inc (INBS) - Stock Titan
INBS (INBS) director receives 5,000 restricted shares in equity award - stocktitan.net
Intelligent Bio Solutions (NASDAQ: INBS) grants director 5,000 restricted shares - Stock Titan
INBS (INBS) CFO receives time- and performance-based restricted stock grants - Stock Titan
Director at Intelligent Bio Solutions (INBS) granted 5,000 shares - Stock Titan
Director at Intelligent Bio Solutions (INBS) awarded 5,000 restricted shares - Stock Titan
INBS (INBS) CEO receives time- and performance-based restricted stock grants - Stock Titan
Intelligent Bio Solutions Inc.: Fundamental Analysis and Financial Ratings | 12Q | US36151G7097 - marketscreener.com
Aug Setups: Is Intelligent Bio Solutions Inc part of any major index2026 Trends & Weekly Breakout Watchlists - baoquankhu1.vn
Why Is INBS Stock Rising Today? - Dailyhunt
Intelligent Bio Solutions Inc. (INBS) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Why Intelligent Bio Solutions Inc. stock is rated strong buyJuly 2025 Short Interest & Weekly High Return Stock Opportunities - Naître et grandir
How Intelligent Bio Solutions Inc. stock reacts to global recession fearsWeekly Profit Analysis & Target Return Focused Picks - Naître et grandir
Intelligent Bio Solutions announces reverse stock split - MSN
Jobs Data: Should you buy the dip on Intelligent Bio Solutions IncPortfolio Performance Summary & Weekly Breakout Watchlists - baoquankhu1.vn
Why Did INBS Stock Fall 17% Today? - Stocktwits
Intelligent Bio Solutions Scales Manufacturing to Fuel Growth and U.S. Ambitions - AD HOC NEWS
HealthEquity (NASDAQ:HQY) & Intelligent Bio Solutions (NASDAQ:INBS) Head to Head Comparison - Defense World
Jobs Data: How cyclical is Intelligent Bio Solutions Incs revenue stream2025 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
INBS receives first reader shipment from Syrma Johari partnership By Investing.com - Investing.com Australia
INBS receives first reader shipment from Syrma Johari partnership - Investing.com
Intelligent Bio Solutions Expands Manufacturing Capacity and Deployment - TipRanks
Intelligent Bio Solutions Inc. Plans U.S. Market Entry in 2026 - marketscreener.com
Why Did INBS Stock Jump 11% In Pre-Market Today? - Asianet Newsable
Intelligent Bio Solutions ships first readers with Syrma Johari, targets 40% production cost cuts - TradingView
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio Solutions announces delivery in partnership with Syrma Johari - marketscreener.com
Intelligent Bio Solutions (INBS) targets 40%+ cost savings with new Syrma Johari manufacturing - Stock Titan
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry - The Manila Times
Intelligent Bio Solutions Announces Delivery In Partnership With Syrma Johari - TradingView
Drug test readers scaled 4x as Intelligent Bio preps for U.S. entry - Stock Titan
Aug Final Week: What are the analyst revisions for CLFDIs ARQQW stock a good investment in YEARTrend Reversal & Fast Moving Trade Plans - baoquankhu1.vn
Aug Fed Impact: Will D Wave Quantum Inc Equity Warrant stock benefit from M AJuly 2025 Breakouts & Verified Swing Trading Watchlists - baoquankhu1.vn
Intelligent Bio Solutions (INBS) Collaborates with Bouygues UK o - GuruFocus
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):